The objective of the OLP Registry is to collect more data on the post-transplant clinical outcomes of DBD and DCD donor livers preserved and assessed on OCS Liver System according to the approved indication and the OCS device performance in the real-world setting.
OLP Registry is a multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below.
Study Type
OBSERVATIONAL
Enrollment
166
Multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below.
University of Alabama
Birmingham, Alabama, United States
University of California San Diego
La Jolla, California, United States
University of California San Francisco
San Francisco, California, United States
Emory
Patient Survival
1-year patient survival with the originally transplanted liver (patient and graft survival) post-Liver transplant.
Time frame: 1 year post-Liver transplant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Atlanta, Georgia, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Duke Medical Center
Durham, North Carolina, United States
Houston Methodist
Houston, Texas, United States